GMP Cytokines Market

Cytokines are a large group of small signalling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well.
GMP Cytokines are intended for use in GMP manufacturing of investigational or marketed clinical products, such as cell therapy, gene therapy, tissue-engineered products and other fields.
GMP Cytokines Market aims to provide a comprehensive presentation of the global market for GMP Cytokines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GMP Cytokines. GMP Cytokines Market contains market size and forecasts of GMP Cytokines in global, including the following market information:
Global GMP Cytokines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global GMP Cytokines Market Sales, 2018-2023, 2024-2029, (mg)
Global top five GMP Cytokines companies in 2022 (%)
The global GMP Cytokines market was valued at US$ 130.3 million in 2022 and is projected to reach US$ 223.8 million by 2029, at a CAGR of 8.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of GMP cytokines include Bio-Techne, PeproTech, CellGenix, Miltenyi Biotec, Cytiva and Lonza, etc. Top 5 players occupy for a share about 65%. North America is the largest market, with a share about 54%, followed by Europe and Asia-Pacific. In terms of product, growth factor is the largest segment, with a share about 55%. In terms of application, cell/gene therapy is the largest market, with a share over 54%.
We surveyed the GMP Cytokines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global GMP Cytokines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (mg)
Global GMP Cytokines Market Segment Percentages, by Type, 2022 (%)
TNF
Interleukin
Growth Factor
Others
Global GMP Cytokines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (mg)
Global GMP Cytokines Market Segment Percentages, by Application, 2022 (%)
Cell/Gene Therapy
Tissue-Engineered Products
Others
Global GMP Cytokines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (mg)
Global GMP Cytokines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies GMP Cytokines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies GMP Cytokines revenues share in global market, 2022 (%)
Key companies GMP Cytokines sales in global market, 2018-2023 (Estimated), (mg)
Key companies GMP Cytokines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bio-Techne
PeproTech
CellGenix
Miltenyi Biotec
Cytiva
Lonza
ReproCELL
Sino Biological
Akron Biotech
Creative Bioarray
Outline of Major Chapters:
Chapter 1: Introduces the definition of GMP Cytokines, market overview.
Chapter 2: Global GMP Cytokines market size in revenue and volume.
Chapter 3: Detailed analysis of GMP Cytokines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of GMP Cytokines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global GMP Cytokines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.